Abstract

Several studies showed that D-Limonene can improve metabolic parameters of obese mice via various mechanisms, including intestinal microbiota modulation. Nevertheless, its effective doses often overcome the acceptable daily intake, rising concerns about toxicity. In this study we administered to C57BL/6 mice for 84 days a food supplement based on D-Limonene, adsorbed on dietary fibers (FLS), not able to reach the bloodstream, to counteract the metabolic effects of a high-fat diet (HFD). Results showed that daily administration of D-Limonene (30 and 60 mg/kg body weight) for 84 days decreased the weight gain of HFD mice. After 84 days we observed a statistically significant difference in weight gain in the group of mice receiving the higher dose of FLS compared to HFD mice (35.24 ± 4.56 g vs. 40.79 ± 3.28 g, p < 0.05). Moreover, FLS at both doses tested was capable of lowering triglyceridemia and also fasting glycemia at the higher dose. Some insights on the relevant fatty acid changes in hepatic tissues were obtained, highlighting the increased polyunsaturated fatty acid (PUFA) levels even at the lowest dose. FLS was also able to positively modulate the gut microbiota and prevent HFD-associated liver steatosis in a dose-dependent manner. These results demonstrate that FLS at these doses can be considered non-toxic and could be an effective tool to counteract diet-induced obesity and ameliorate metabolic profile in mice.

Highlights

  • MeasureOralleads administration of D-Limonene mg/kg) in the free form dissolved in ments, showing a maximum peak

  • Orcapable of counteracting obesity with multitarget positive effects in rodent models.ofOrange essential oil (EO) microencapsulated into beta-cyclodextrin has been used in a model obesity ange microencapsulated into beta-cyclodextrin has been used in a model of obesity obtained by feeding rats with a high-fat diet (HFD) [11]

  • This study demonstrated an anti-obesity effect of orange EO by significantly decreasing body weight gain, alleviating liver pathological of orange EO by significantly decreasing body weight gain, alleviating liver pathological alteration and ameliorating HFD-related biochemical parameters, such as the total cholesalteration and ameliorating HFD-related biochemical parameters, such as the total cholesterol blood level

Read more

Summary

Introduction

Obesity is a chronic relapsing multifactorial disease affecting about 13% of adults worldwide and is one of the leading risk factors for premature death [1]. There are multiple causes that lead to the deregulation of neuroendocrine mechanisms that regulate energy balance and body weight. Genetic, epigenetic and environmental ones are well recognized [2]. Sedentary life and high consumption of sugars and fats are closely associated with this disease. Dysfunction of the adipose organ, systemic inflammation and alteration of the intestinal microbiota contribute to chronicization and the onset of Pharmaceutics 2021, 13, 1753.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call